XML 42 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Sep. 30, 2012
Accounting Policies [Abstract]  
Schedule of Fair Value Measurements of Marketable Securities

Fair value of assets and liabilities measured on a recurring basis at September 30, 2012 and 2011 are as follows:

 

Fair Value Measurements at Reporting Date Using:    
         
  Fair Value Quoted Prices In Active
Markets for Identical
Assets/Liabilities (Level 1)
Level 2 Level 3
September 30, 2012        
Available-for-sale securities $2,271,721 $2,271,721 $- $-
         
September 30, 2011        
Available-for-sale securities $2,267,268 $2,267,268 $- $-

 

Schedule of Marketable Securities

A summary of the marketable securities at September 30, 2012, 2011 and 2010 is as follows:

   Cost Basis   Unrealized Gain   Unrealized Loss   Market Value 
2012                    
Cash and equivalents  $140,186   $   $   $140,186 
MetLife stock value   51,185            51,185 
Government and agency issues   75,001    857        75,858 
Corporate bonds   196,842    3,754        200,596 
Mutual funds   144,148        6,723    137,425 
Equity securities   1,588,755    77,716        1,666,471 
Total securities  $2,196,117   $82,327   $6,723   $2,271,721 
                     
2011                    
Cash and equivalents  $55,185   $   $   $55,185 
MetLife stock value   51,185            51,185 
Government and agency issues   149,975    586        150,561 
Corporate bonds   560,606    3,727        564,333 
Mutual funds   185,762        19,628    166,134 
Equity securities   1,391,555        111,685    1,279,870 
Total securities  $2,394,268   $4,313   $131,313   $2,267,268 
                     
2010                    
Cash and equivalents  $116,206   $   $   $116,206 
MetLife stock value   51,185            51,185 
Government and agency issues   100,000    923        100,923 
Corporate bonds   593,861    21,678        615,539 
Mutual funds   125,547        5,821    119,726 
Equity securities   1,315,751    47,540        1,363,291 
Total securities  $2,302,550   $70,141   $5,821   $2,366,870 

 

Schedule of Stock Based Compensation

Information regarding shares of stock awarded to directors in fiscal 2012 is summarized below.

 

  Fees Earned or Paid 2/22/2012    
  in Cash Stock Awards Stock Awards Total
  ($) (@ $12.975/Share) ($) ($)
6 Directors  - 6,750 87,581 87,581
         
Schedule of Investment in Joint Ventures

 

Initial investment in joint ventures  $111,000 
Earnings in joint ventures   238,193 
Ending balance in investment in joint ventures  $349,193